Search Results
Aug 10, 2026, 05:58 ET Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: DJS Law Group LLP
Aug 10, 2026, 04:52 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: Schall, Brown & Schwartz LLP
Aug 08, 2026, 12:35 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as
More news about: THE ROSEN LAW FIRM, P. A.
Aug 07, 2026, 22:00 ET Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NasdaqGS: CAPR), if they purchased Capricor securities between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"). This action is pending in the United
More news about: ClaimsFiler
Aug 07, 2026, 11:10 ET INVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - CAPR
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, both dates inclusive (the "Class Period"), have until September 28, 2026 to seek appointment
More news about: Robbins Geller Rudman & Dowd LLP
Aug 06, 2026, 13:52 ET CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
FRANCISCO, Aug. 6, 2026 /PRNewswire/ -- Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to
More news about: Hagens Berman Sobol Shapiro LLP
Aug 06, 2026, 12:30 ET Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
action lawsuit against Capricor Therapeutics, Inc. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CAPRICOR THERAPEUTICS, INC. (CAPR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE SEPTEMBER 28, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD
More news about: Law Offices of Howard G. Smith
Aug 06, 2026, 12:00 ET Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ: CAPR) and certain of its officers.
More news about: Bronstein, Gewirtz & Grossman, LLC
Aug 06, 2026, 10:07 ET SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 28, 2026 in Capricor Therapeutics, Inc. Lawsuit - CAPR
Top 50 Report as one of the top securities litigation firms in the United States.Frequently Asked Questions About the CAPR LawsuitQ: How much did CAPR stock drop? A: Shares fell approximately 78.7%, a decline of an aggregate $15.08 per share across two corrective disclosures,
More news about: SueWallSt.com
Aug 06, 2026, 05:15 ET Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: DJS Law Group LLP
Aug 06, 2026, 04:24 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: Schall, Brown & Schwartz LLP
Aug 05, 2026, 13:20 ET Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announces that investors with losses related to Capricor Therapeutics, Inc. (CAPR) have opportunity to lead the securities fraud class action lawsuit.
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Aug 05, 2026, 10:09 ET Capricor (CAPR) Securities Investigation Notice - Levi & Korsinsky
Therapeutics, Inc. (NASDAQ: CAPR) shareholders were hit with a 60% to 70% drop on July 27, 2026, after FDA briefing documents for Deramiocel raised significant concerns with cardiac efficacy and a post-randomization statistical analysis plan change. If that collapse reduced the value of your CAPR position, action
More news about: Levi & Korsinsky, LLP
Aug 05, 2026, 10:07 ET Levi & Korsinsky Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026 - CAPR
as lead plaintiff.Frequently Asked Questions About the CAPR LawsuitQ: What is the CAPR class action lawsuit about? A: A securities class action has been filed against Capricor Therapeutics, Inc. (NASDAQ: CAPR) alleging materially false and misleading statements between December
More news about: Levi & Korsinsky, LLP
Aug 04, 2026, 06:36 ET CAPR Stock Drop: Capricor Therapeutics Clinical Data Leads to 64% Stock Drop and Securities Fraud Class Action for Investors
Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ: CAPR) and certain of the company's senior executives for securities fraud after its significant stock drop resulting from potential violations
More news about: Bleichmar Fonti & Auld LLP
Aug 03, 2026, 17:45 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as
More news about: THE ROSEN LAW FIRM, P. A.
Aug 03, 2026, 16:02 ET CAPR INVESTOR ALERT: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Capricor Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), have until September 28, 2026 to seek appointment as lead plaintiff
More news about: Robbins Geller Rudman & Dowd LLP
Aug 03, 2026, 01:00 ET Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: DJS Law Group LLP
Aug 03, 2026, 01:00 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: Schall, Brown & Schwartz LLP
Jul 30, 2026, 13:24 ET CAPR Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Urged to Contact Hagens Berman; Investigation Opened Following Massive Stock Crash
www.hbsslaw.com/investor-fraud/capr Contact the Firm Now: [email protected] 844-916-0895Capricor Therapeutics (CAPR) InvestigationThe
More news about: Hagens Berman Sobol Shapiro LLP
Jul 30, 2026, 10:24 ET CAPR SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Capricor
2026 sent Capricor (NASDAQ: CAPR) shares down 60% to 70% after reviewers raised significant concerns with Deramiocel ahead of the July 29 advisory committee meeting. If your CAPR shares fell on this FDA briefing news, your losses may be part of the pending investigation. CAPR shareholders who suffered
More news about: SueWallSt.com
Jul 30, 2026, 03:58 ET Rosen Law Firm Encourages Capricor Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - CAPR
investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Capricor Therapeutics Inc. (NASDAQ: CAPR) resulting from allegations that Capricor may have issued materially misleading business information to the investing public.So what: If you purchased
More news about: THE ROSEN LAW FIRM, P. A.
Jul 29, 2026, 19:29 ET Securities Fraud Investigation Into Capricor Therapeutics, Inc. (CAPR) Announced Concerning FDA Review And Advisory Committee Meeting - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
IF YOU ARE AN INVESTOR WHO LOST MONEY ON CAPRICOR THERAPEUTICS, INC. (CAPR), CLICK
More news about: Glancy Prongay Wolke & Rotter LLP
Jul 29, 2026, 18:45 ET Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR)
professionals. Hundreds of millions recovered.Frequently Asked Questions About the CAPR InvestigationQ: Who is eligible to participate in the CAPR investigation?A: Investors who purchased CAPR stock or securities and suffered financial losses may be eligible. Eligibility is based on
More news about: Levi & Korsinsky, LLP
Oct 28, 2025, 14:20 ET Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Contact Law Firm
PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) breached their fiduciary duties to shareholders.
More news about: Kuehn Law, PLLC